Bradley D. Smith
Emil T. Hofman Professor of Science
Recognized nationally and internationally in the field of supramolecular chemistry, Bradley Smith has made the development of novel fluorescent imaging probes to detect tumors, dying tissues, and bacterial infections a major aim of his research. These imaging probes promise to accelerate the often lengthy and arduous pre-clinical stages of drug discovery and development.
In early 2010, Notre Dame awarded an exclusive license to a U.S.-based biotechnology company to commercialize a novel sensing technology developed by Smith. The technology, which can selectively target dead or dying mammalian cells, as well as bacteria, could offer healthcare professionals the means to intervene earlier and more effectively in a range of diseases, from cancers and cardiovascular disease, to renal diseases, bacterial infections, Alzheimer’s, and even transplant rejection.
Smith is the founding director of the Notre Dame Integrated Imaging Facility, which, since 2008, has provided researchers from across campus with a consolidated, state-of-the-art research core devoted to offering the latest in imaging technologies and encouraging interdisciplinary collaborations.
The Hofman Professorship was endowed by Notre Dame Trustee and parent Fritz L. Duda. He and his wife, Mary Lee, have established professorships in each of Notre Dame’s colleges and schools. This position honors Notre Dame’s legendary chemistry professor and dean emeritus of the College of Science, Emil T. Hofman.